Gastroenterology Doctors in Costa Mesa, CA Accepting Medicare

2 Gastroenterology doctors found. Showing 1 - 2

Ashkan Farhadi, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 722 Baker St, Memorial Care Medical Group, Costa Mesa, CA 92626 Phone: 714-966-9523

Khoi M Tran, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 1640 Newport Blvd, Ste 350, Costa Mesa, CA 92627 Phone: 949-386-5260    Fax: 949-515-0031

News Archive

Drug combo gives lung cancer patients longer life

Preliminary results from a large randomized clinical trial, sponsored by the National Cancer Institute (NCI), by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., have shown that patients with previously untreated advanced non-squamous non-small cell lung cancer who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

New minimally-invasive procedure to treat jackhammer esophagus

Six weeks ago 67-year old John Galbreath welcomed death, rather than live one more day. Intense pain in his chest had left him nearly bedridden for four months. Galbreath had a condition called jackhammer esophagus, which made him feel like the name suggests—like a jackhammer was going off in his chest.

Accellent expects net sales of $124.5 million to $125.5 million for fiscal third quarter 2010

Accellent Inc. a wholly owned subsidiary of Accellent Holdings Corp. today announced certain preliminary financial information for its fiscal third quarter ended September 30, 2010. Such information remains preliminary and subject to review by our independent public accountants.

Genervon reports new findings that drug candidate GM6 attenuates Alzheimer's disease in mice model

Following the closure of several research programs for Alzheimer's disease, in early 2018 the FDA issued a release entitled "Draft Guidance for Industry: Early Alzheimer's Disease: Developing Drugs for Treatment." Encouraged by the proposed changes in the new guidance, Genervon's research team reported new findings that its drug candidate GM6 attenuates Alzheimer's disease in an early AD transgenic APP mice model.

Changes in midlife wealth influence cardiovascular health

A relative decline in wealth during midlife increases the likelihood of a cardiac event or heart disease after age 65 while an increase in wealth between ages 50 and 64 is associated with lower cardiovascular risk, according to a new study in JAMA Cardiology.

Read more Medical News

› Verified 2 days ago